CNX Therapeutics
Dr Benjamin Moore currently holds the position of Vice President Corporate Development at CNX Therapeutics Ltd. Prior to this role, Dr Moore has held various senior positions in corporate development, business development, and commercial strategy at companies such as Mundipharma, Zentiva, and MSD. With a strong educational background in Natural Science and a Ph.D. in Biochemistry from University of Cambridge and Imperial College London, Dr Moore brings a wealth of knowledge and expertise to their current role in the pharmaceutical industry.
CNX Therapeutics
2 followers
CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We commercialise and distribute a portfolio of speciality brands and hospital products in Europe, in 40 countries worldwide, both directly and through strategic partnerships. Our vision is to become a recognised partner of choice through our commercial excellence, patient focus and presence across Europe.